liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Drug combinatorics and side effect estimation on the signed human drug-target network
University of Politecn Cataluna, Spain.
Linköpings universitet, Institutionen för systemteknik, Reglerteknik. Linköpings universitet, Tekniska fakulteten.ORCID-id: 0000-0003-4142-6502
2016 (engelsk)Inngår i: BMC Systems Biology, ISSN 1752-0509, E-ISSN 1752-0509, Vol. 10, nr 74Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background: The mode of action of a drug on its targets can often be classified as being positive (activator, potentiator, agonist, etc.) or negative (inhibitor, blocker, antagonist, etc.). The signed edges of a drug-target network can be used to investigate the combined mechanisms of action of multiple drugs on the ensemble of common targets. Results: In this paper it is shown that for the signed human drug-target network the majority of drug pairs tend to have synergistic effects on the common targets, i.e., drug pairs tend to have modes of action with the same sign on most of the shared targets, especially for the principal pharmacological targets of a drug. Methods are proposed to compute this synergism, as well as to estimate the influence of the drugs on the side effect of another drug. Conclusions: Enriching a drug-target network with information of functional nature like the sign of the interactions allows to explore in a systematic way a series of network properties of key importance in the context of computational drug combinatorics.

sted, utgiver, år, opplag, sider
BIOMED CENTRAL LTD , 2016. Vol. 10, nr 74
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-131906DOI: 10.1186/s12918-016-0326-8ISI: 000383020500001PubMedID: 27526853OAI: oai:DiVA.org:liu-131906DiVA, id: diva2:1034863
Merknad

Funding Agencies|Swedish Research Council [2015-04390]

Tilgjengelig fra: 2016-10-13 Laget: 2016-10-11 Sist oppdatert: 2018-01-14

Open Access i DiVA

fulltext(1509 kB)86 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1509 kBChecksum SHA-512
a53a7a8ebcc55dd6036d83d986c1fd23780274a47f4ce6ee3d4545fcf3e2707be891051e05c82f456ffc1a94f6730fa9da4121dbd6754b780aa1f4aff5857219
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Altafini, Claudio
Av organisasjonen
I samme tidsskrift
BMC Systems Biology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 86 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 587 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf